New weight drug HU6 tested in early human study
NCT ID NCT07170189
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 35 times
Summary
This early-stage study looked at how safe a new drug called HU6 is and how the body processes it. Fifty-nine overweight adults took HU6 as tablets or capsules, either with or without food. The main goal was to measure drug levels in the blood, not to treat or cure a condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nucleus Network
Minneapolis, Minnesota, 55114, United States
Conditions
Explore the condition pages connected to this study.